Estimates that Medicaid prescription drug coverage for approximately 6 million "dual eligibles"—low-income seniors and people with disabilities who are covered by both Medicaid and Medicare—accounts for nearly half of all Medicaid spending on prescription drugs, including both...

These remarks, presented at the Brookings Institution's Stakeholder Forum on After-School Programs, reflect on lessons from the 21st Century Community Learning Centers study that can benefit future education evaluations. Specifically, the author calls for consistent weighting of the evidence,...

Medicare reform is at the top of the domestic policy agenda, and the role of private plans in that reform is a critical factor. Most of Medicare's experience with private plans has involved the Medicare+Choice (M+C) program. M+C plans, primarily HMOs, receive capitated payments and provide...

Eligibility expansion for low-income children and families under Medicaid and the State Children’s Health Insurance Program has improved access to physician care for many, but problems continue to persist. This report provides a framework for states to use in assessing factors that promote or...

The authors estimate the social welfare associated with the Medicare+Choice program at approximately $18.7 billion in consumer surplus and $52 billion in HMO profits from 1993 to 2000. Conservatively, the estimated total net social welfare from the M+C program is $24.8 billion. Prescription drug...